Carlsmed (CARL) Operating Expenses (2024 - 2026)

Carlsmed's Operating Expenses history runs 3 years deep, the most recent figure standing at $21.7 million for Q1 2026.

• Quarterly Operating Expenses rose 62.49% year-over-year to $21.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $77.0 million (up 58.58% YoY) and the FY2025 annual result came in at $68.6 million, up 55.34% from the prior year.
• Operating Expenses was $21.7 million for Q1 2026 at Carlsmed, up from $20.9 million in the prior quarter.
• Across five years, Operating Expenses topped out at $21.7 million in Q1 2026 and bottomed at $10.9 million in Q2 2024.
• A 3-year average of $15.7 million and a median of $14.4 million in 2025 frame the typical range for Operating Expenses.
• Peak annual rise in Operating Expenses reached 78.53% in 2025, while the deepest fall reached 41.26% in 2025.
• Carlsmed's Operating Expenses stood at $11.7 million in 2024, then surged by 78.53% to $20.9 million in 2025, then advanced by 3.7% to $21.7 million in 2026.
• Business Quant data shows CARL's Operating Expenses at $21.7 million in Q1 2026, $20.9 million in Q4 2025, and $19.0 million in Q3 2025.